Ultimately, the choice of weight management approach should be individualised , considering your medical history, preferences, and circumstances, in partnership with your healthcare team
[DOI] [PubMed] [Google Scholar] 56
difficile infection following antibiotic use Signs of dehydration , including dark urine, dizziness, reduced urination, dry mouth, or feeling faint when standing Severe abdominal pain , particularly if accompanied by fever, as this could indicate complications unrelated to medication side effects Palpitations or irregular heartbeat which may suggest cardiac rhythm disturbances Signs of pancreatitis , such as severe upper abdominal pain radiating to the back, persistent nausea, or vomiting, as Wegovy carries a rare risk of this serious condition Symptoms of hypoglycaemia (if also taking insulin or sulfonylureas) such as sweating, shakiness, confusion, or extreme hunger Contact your GP or prescriber if you experience moderate gastrointestinal symptoms that interfere with daily activities or prevent you from maintaining adequate nutrition and hydration
You want FDA approval specifically for weight management
Eating 2030 g protein (30 g if over 50) across 35 daily meals supports muscle retention and hunger control for semaglutide users
Tirzepatide targets GLP-1 and GIP receptors, while semaglutide targets only GLP-1 receptors
